Ethical issues, including those related to Institutional Review Boards, in the conduct of clinical trials research.

Selected Publications

Arndt C, Hawkins D, Anderson JR, Breitfeld P, Womer R, Meyer W.  Age is a risk factor for chemotherapy-induced hepatopathy with vincristine, dactinomycin, and cyclophosphamide.  J Clin Oncol. 22:1894-901, 2004.

Sung L, Anderson JR, Donaldson SS, Spunt SL, Crist WM, Pappo AS.  Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Eur J Cancer. 2004 Aug;40(12):1878-85.

Rupp ME, Fitzgerald T, Marion N, Helget V, Puumala S, Anderson JR, Fey PD.  Effect of silver-coated urinary catheters: Efficacy, cost-effectiveness, and antimicrobial resistance.  Am J Infect Control, 34:445-50, 2004.

Chiu B C-H, Kolar C, Gapstur SM, Lawson T, Anderson JR, Weisenburger DD. Association of NAT and GST polymorphisms with non-Hodgkins lymphoma: a population-based case-control study. British J Haematology 128:610-15, 2005.

Enose Y, Destache CJ, Mack AL, Anderson JR, Ullrich F, Ciborowski PS, Gendelman HE. Proteomic fingerprints distinguish microglia, bone marrow, and spleen macrophage populations.  Glia. 51(3):161-72, 2005.

Donaldson SS, Anderson JR. Rhabdomyosarcoma: many similarities, a few philosophical differences (editorial). J Clin Oncol. 2005 Apr 20;23(12):2586-7.

Anderson JR (letter). More on data monitoring and large apparent treatment effects. Contemp Clin Trials 26:416-17, 2005.

Professional Affiliations

Children's Oncology Group